Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108689901B reveals a mild, base-mediated route to aziridines. This method offers high yields and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN114853692B reveals a novel solvent-free catalytic route for 2-aminothiazole, delivering >95% yield and 99% purity while drastically reducing manufacturing costs.
Patent CN111423381B details a mild 30°C Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN114507180B reveals metal-free C(sp3)-H activation enabling cost reduction in pharmaceutical intermediate manufacturing with high purity and supply reliability.
Patent CN113999201A details a novel asymmetric synthesis of S-nicotine, offering high purity and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN111423381A reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN112441978B reveals a novel route for MHPE production using DEMME, offering significant cost reduction and high purity for Topramezone manufacturing.
Patent CN113121462B reveals a metal-free route for 5-trifluoromethyl-1,2,3-triazoles, offering safer manufacturing and cost reduction in API intermediate production.
Patent CN112480015B details a novel one-pot synthesis for 2-trifluoromethyl quinazolinones using nitro compounds, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Patent CN115181081A details a green asymmetric Baeyer-Villiger oxidation using an ionic cobalt complex. This method offers high yield, recyclability, and cost reduction in pharmaceutical intermediates manufacturing.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles offers cost-effective routes for API manufacturing with high purity and scalability.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chain solutions.
Novel Pd-catalyzed multicomponent method for indolinone-imidazole derivatives. Safe, scalable, CO-free process for high-purity pharmaceutical intermediates.
Discover a cost-effective synthetic method for indeno-[1,2-b]indole-10(5H)-one compounds via patent CN108503578B, offering superior purity and supply chain stability.
Novel FeCl3-catalyzed cyclization method offers high yields and cost-effective production for pharmaceutical intermediates.
Novel silver oxide promoted method offers high purity pharmaceutical intermediates with simplified supply chain and cost reduction potential.
Patent CN111072605B details a visible-light catalyzed method for fluoroalkyl-substituted benzofurans. Offers mild conditions and high yields for pharma intermediates.
Patent CN112239384B reveals a robust Ni-catalyzed carbonylation route for thioesters, offering cost-effective API intermediate manufacturing.
Patent CN115286578B reveals a metal-free route for trifluoromethyl pyrazoles. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable supply solutions.
Novel Mo/Cu co-catalyzed method for 3-trifluoromethyl-1,2,4-triazoles offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.